OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
June 03, 2021
In addition to ADCs, other types of highly potent biologics require specialized manufacturing skills.
May 19, 2021
Sandoz plans to strengthen its European antibiotics manufacturing network by expanding its production capabilities in Kundl, Austria, and Palafolls, Spain.
Colorcon’s new suite will provide clients with capabilities to develop prototype tablets or capsule dosage forms when API quantity is limited or the API potency requires a higher level of protection.
May 03, 2021
Applying a QbD approach helps address excipient variability and other quality features.
April 03, 2021
Topical drugs are attractive to patients, but these complex products pose challenges for formulators.
March 03, 2021
Without an independent approval pathway for novel excipients, true pharmaceutical innovation could be stymied.
December 14, 2020
The company will expand the site to include six new containment isolators and a product development manufacturing laboratory.
December 03, 2020
Operator, caregiver, and patient safety are at the forefront when selecting the best options and dosage forms.
November 11, 2020
Construction on the workshop is currently underway with plans for it to be fully operational by the end of 2021.
November 03, 2020
Biological and analytical advances enable modern fermentation processes to deliver safe and effective next-generation medicines.